The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats

Pediatric Research

Volumn 41, Issue 3, 1997, Pages 327-333

  Wassberg, Erik ^a,d   Påhlman, Sven ^b   Westlin, Jan Erik ^c   Christofferson, Rolf ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN; ENOLASE; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RAT; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT;

EID: 0342683814     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199703000-00004     Document Type: Article

References (31)

1. Voûte PA, de Kraker J, Hoefnagel CA 1992 Tumors of the sympathetic nervous system: neuroblastoma, ganglioneuroma and phaeochromocytoma. In: Voûte PA, Barrett A, Lemerle J (eds) Cancer in Children - Clinical Management , 3rd Ed. Springer-Verlag, New York, pp 226-243
2. Ninane J 1992 Neuroblastoma. In: Plowman PN and Pinkerton CR (eds) Paediatric Oncology - Clinical practice and controversies. Chapman & Hall Medical, London, pp 351-377
3. Bowman LC, Hancock ML, Santana VM, Hayes FA, Kun L, Parham DM, Furman WL, Rao BN, Green AA, Crist WM 1991 Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital Experience, 1962 to 1988. J Clin Oncol 9:1599-1608
4. Brodeur GM, Castleberry RP 1993 Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology. JB Lippincott, Philadelphia, pp 739-767
5. Humpl T 1995 Neuroblastoma. World J Urol 13:233-239
6. Kallinowski F, Schlenger KH, Runkel S, Kloes M, Stohrer M, Okunieff P, Vaupel P 1989 Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res 49:3759-3764
7. Kjønniksen I, Winderen M, Bruland Ø, Fodstad Ø 1994 Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats. Cancer Res 54:1715-1719
8. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS 1978 Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38:3751-3757
9. Påhlman S, Hoehner JC, Nånberg E, Hedborg F, Fagerström S, Gestblom C, Johansson I, Larsson U, Lavenius E, Örtoft E, Söderholm H 1995 Differentiation and survival influences of growth factors in human neuroblastoma. Eur J Cancer 31A:453:458
10. Hougen HP 1991 The athymic nude rat. APMIS Suppl 21, 99:7-39
11. Folkman J 1971 Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186
12. Folkman J 1995 Tumor angiogenesis. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds) The Molecular Basis of Cancer. WB Saunders, Philadelphia, pp 206-232
13. 1 phase of the cell cycle. Cancer Res 54:2073-2076
14. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J 1990 Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348:555-557
15. Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J 1991 Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174:1070-1076
16. Kusaka M, Sudo K, Matsutani E, Kozai Y, Marui S, Fujita T, Ingber D, Folkman J 1994 Cytostatic inihibition of endothelial cell growth by the angiogenesis inihibitor TNP-470 (AGM-1470). Br J Cancer 69:212-216
17. Biedler JL, Helson L, Spengler BA 1973 Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652
18. Larsson R, Nygren P 1990 Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay.
19. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells. Int J Cancer 46:67-72
20. Tomayko MM, Reynolds CP 1989 Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24:148-154
21. Elias H, Hyde DM 1980 Elementary stereology. Am J Anat 159:411-446
22. Rentrop M, Knapp B, Winter H, Schweizer J 1986 Aminoalkylsilane-treated glass slides as support for in situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditions. Histochem J 18:271-276
23. Påhlman S, Mamaeva S, Meyerson G, Mattson MEK, Bjelfman C, Örtoft E, Hammerling U 1990 Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol Scand 140:25-37
24. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D 1985 Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116
25. Brodeur GM 1995 Molecular basis for heterogeneity in human neuroblastomas. Eur J Cancer 31A:505-510
26. Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Kowe ST, Valentine MB, Komuro H, Castleberry RP, Bowman LC, Rao PV, Seeger RC, Brodeur GM 1995 Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a pediatric oncology group study. Cancer Res 55:721-726
27. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J 1994 Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328
28. Brem H, Folkman J 1993 Analysis of experimantal antiangiogenic therapy. J Pediatr Surg 28:445-451
29. Folkman J, Ingber D 1992 Inhibition of angiogenesis. Semin Cancer Biol 3:89-96
30. Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K, Fujita T 1993 Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetylcarbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res 53:4262-4267
31. Teicher BA, Holder SA, Ara G, Alvarez Sotomayor E, Huang ZD, Chen Y-N, Brem H 1994 Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogemc agents. Int J Cancer 57:920-925